1 documents found
Information × Registration Number 0115U001864, R & D request Title 24-week, randomized, double-blind, double masking phase III study in parallel groups (with the extension to 52 weeks in a subgroup of patients), comparing with the efficiency, safety and tolerability of a fixed dose combination of fluticasone furoate triple / umeklidinu / vilanterolu applicable once daily dry powder inhaler using, and combinations of budesonide / formoterol 400 mg / 12 mg, applied twice a day using tank inhaler in patients from chronic obstructive disease lehen Head Скрипник Ігор Миколайович, Registration Date 11-09-2015 Organization Ukrainian medical stomatological Academy popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
24-week, randomized, double-blind, double masking phase III study in parallel groups (with the extension to 52 weeks in a subgroup of patients), comparing with the efficiency, safety and tolerability of a fixed dose combination of fluticasone furoate triple / umeklidinu / vilanterolu applicable once daily dry powder inhaler using, and combinations of budesonide / formoterol 400 mg / 12 mg, applied twice a day using tank inhaler in patients from chronic obstructive disease lehen
Head: Скрипник Ігор Миколайович. 24-week, randomized, double-blind, double masking phase III study in parallel groups (with the extension to 52 weeks in a subgroup of patients), comparing with the efficiency, safety and tolerability of a fixed dose combination of fluticasone furoate triple / umeklidinu / vilanterolu applicable once daily dry powder inhaler using, and combinations of budesonide / formoterol 400 mg / 12 mg, applied twice a day using tank inhaler in patients from chronic obstructive disease lehen. Ukrainian medical stomatological Academy. № 0115U001864
1 documents found

Updated: 2026-03-27


Роздрукувати цю сторінку